These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 19162022)

  • 1. Conformation-dependent single-chain variable fragment antibodies specifically recognize beta-amyloid oligomers.
    Wang XP; Zhang JH; Wang YJ; Feng Y; Zhang X; Sun XX; Li JL; Du XT; Lambert MP; Yang SG; Zhao M; Klein WL; Liu RT
    FEBS Lett; 2009 Feb; 583(3):579-84. PubMed ID: 19162022
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Direct in vivo intracellular selection of conformation-sensitive antibody domains targeting Alzheimer's amyloid-beta oligomers.
    Meli G; Visintin M; Cannistraci I; Cattaneo A
    J Mol Biol; 2009 Apr; 387(3):584-606. PubMed ID: 19361429
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anti-oligomeric Abeta single-chain variable domain antibody blocks Abeta-induced toxicity against human neuroblastoma cells.
    Zameer A; Kasturirangan S; Emadi S; Nimmagadda SV; Sierks MR
    J Mol Biol; 2008 Dec; 384(4):917-28. PubMed ID: 18929576
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Single-domain antibodies recognize selectively small oligomeric forms of amyloid beta, prevent Abeta-induced neurotoxicity and inhibit fibril formation.
    Lafaye P; Achour I; England P; Duyckaerts C; Rougeon F
    Mol Immunol; 2009 Feb; 46(4):695-704. PubMed ID: 18930548
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The toxicity of beta-amyloid is attenuated by interaction with its specific human scFv E3 in vitro.
    Yue S; Li Y; Wang X; Bai H; Xia J; Jiang L; Ji Y; Fan L; He Z; Chen Q
    Life Sci; 2008 Jun; 82(25-26):1249-55. PubMed ID: 18505701
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Conformation-dependent scFv antibodies specifically recognize the oligomers assembled from various amyloids and show colocalization of amyloid fibrils with oligomers in patients with amyloidoses.
    Zhang X; Sun XX; Xue D; Liu DG; Hu XY; Zhao M; Yang SG; Yang Y; Xia YJ; Wang Y; Liu RT
    Biochim Biophys Acta; 2011 Dec; 1814(12):1703-12. PubMed ID: 21979582
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Engineered antibody intervention strategies for Alzheimer's disease and related dementias by targeting amyloid and toxic oligomers.
    Robert R; Dolezal O; Waddington L; Hattarki MK; Cappai R; Masters CL; Hudson PJ; Wark KL
    Protein Eng Des Sel; 2009 Mar; 22(3):199-208. PubMed ID: 18927231
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Single chain variable fragments against beta-amyloid (Abeta) can inhibit Abeta aggregation and prevent abeta-induced neurotoxicity.
    Liu R; Yuan B; Emadi S; Zameer A; Schulz P; McAllister C; Lyubchenko Y; Goud G; Sierks MR
    Biochemistry; 2004 Jun; 43(22):6959-67. PubMed ID: 15170333
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Formation of highly toxic soluble amyloid beta oligomers by the molecular chaperone prefoldin.
    Sakono M; Zako T; Ueda H; Yohda M; Maeda M
    FEBS J; 2008 Dec; 275(23):5982-93. PubMed ID: 19021772
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A mimotope peptide of Aβ42 fibril-specific antibodies with Aβ42 fibrillation inhibitory activity induces anti-Aβ42 conformer antibody response by a displayed form on an M13 phage in mice.
    Tanaka K; Nishimura M; Yamaguchi Y; Hashiguchi S; Takiguchi S; Yamaguchi M; Tahara H; Gotanda T; Abe R; Ito Y; Sugimura K
    J Neuroimmunol; 2011 Jul; 236(1-2):27-38. PubMed ID: 21641049
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An anti-Aβ (amyloid β) single-chain variable fragment prevents amyloid fibril formation and cytotoxicity by withdrawing Aβ oligomers from the amyloid pathway.
    Marín-Argany M; Rivera-Hernández G; Martí J; Villegas S
    Biochem J; 2011 Jul; 437(1):25-34. PubMed ID: 21501114
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Isolation and identification of a human single chain Fv antibody against amyloid-beta 1-42 soluble oligomers from a human phage display library].
    Bao F; He J; Cao G; Yin F; Wang X; Pang S; Zhang Y; Hong T
    Sheng Wu Gong Cheng Xue Bao; 2009 Aug; 25(8):1195-203. PubMed ID: 19938457
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synaptic memory mechanisms: Alzheimer's disease amyloid beta-peptide-induced dysfunction.
    Rowan MJ; Klyubin I; Wang Q; Hu NW; Anwyl R
    Biochem Soc Trans; 2007 Nov; 35(Pt 5):1219-23. PubMed ID: 17956317
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of cell-derived oligomers of Abeta in Alzheimer's disease and avenues for therapeutic intervention.
    Walsh DM; Klyubin I; Shankar GM; Townsend M; Fadeeva JV; Betts V; Podlisny MB; Cleary JP; Ashe KH; Rowan MJ; Selkoe DJ
    Biochem Soc Trans; 2005 Nov; 33(Pt 5):1087-90. PubMed ID: 16246051
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Conformation-specific antibodies to target amyloid β oligomers and their application to immunotherapy for Alzheimer's disease.
    Murakami K
    Biosci Biotechnol Biochem; 2014; 78(8):1293-305. PubMed ID: 25130729
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Single chain Fv antibodies against the 25-35 Abeta fragment inhibit aggregation and toxicity of Abeta42.
    Zameer A; Schulz P; Wang MS; Sierks MR
    Biochemistry; 2006 Sep; 45(38):11532-9. PubMed ID: 16981713
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Structural differences of amyloid-β fibrils revealed by antibodies from phage display.
    Droste P; Frenzel A; Steinwand M; Pelat T; Thullier P; Hust M; Lashuel H; Dübel S
    BMC Biotechnol; 2015 Jun; 15():57. PubMed ID: 26084577
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antiparallel beta-sheet: a signature structure of the oligomeric amyloid beta-peptide.
    Cerf E; Sarroukh R; Tamamizu-Kato S; Breydo L; Derclaye S; Dufrêne YF; Narayanaswami V; Goormaghtigh E; Ruysschaert JM; Raussens V
    Biochem J; 2009 Jul; 421(3):415-23. PubMed ID: 19435461
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Amyloid fibril recognition with the conformational B10 antibody fragment depends on electrostatic interactions.
    Haupt C; Morgado I; Kumar ST; Parthier C; Bereza M; Hortschansky P; Stubbs MT; Horn U; Fändrich M
    J Mol Biol; 2011 Jan; 405(2):341-8. PubMed ID: 21059358
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunogenic, antigenic, fibrillogenic and inflammatory properties of new simplified beta-amyloid peptides.
    Rossi M; Piovesan P; Ghirardi O; Mastroianni D; Bombardi V; Battistini L; Cencioni MT; Capobianco D; Borsini F; Colombo M; Verdoliva A
    Mol Immunol; 2009 Aug; 46(13):2524-32. PubMed ID: 19535144
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.